Cap Annual Out-of-Pocket Prescription Drug Costs in Medicare Part D
High prescription drug costs combined with increased out-of-pocket costs (OOP) puts a significant burden on patients, especially those living with serious health conditions like cancer. OOP costs are medical expenses that are not reimbursed by insurance, including deductibles, coinsurance, and copayments.
Currently, there is no cap on annual OOP costs under Medicare Part D (a voluntary outpatient prescription drug benefit). Without a cap, patients with Medicare Part D could pay thousands of dollars out of pocket for their much-needed medications.
Ask your Member of Congress to support efforts to cap annual out-of-pocket costs in Medicare Part D. This will enable cancer patients and others living with serious health conditions to focus on their health and help to reduce the financial burden on patients.